Table 2.

Clinical trial: Proportion seropositive and geometric mean antibody titers

GroupStatisticDay 21Day 28Month 3Month 6Month 12
5.0 logSeropositive28/28 (100%)27/28 (96%)26/26 (100%)21/21 (100%)19/19 (100%)
GMT6,2411,2802,1821,122595
3.0 logSeropositive13/13 (100%)14/14 (100%)9/10 (90%)6/7 (86%)5/5 (100%)
GMT11,3921,2181,194525640